Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

R. Campi, S. D. Brookman-May, Henriquez J. D. Subiela, B. Akdogan, M. Brausi, T. Klatte, J. F. Langenhuijsen, E. Linares-Espinos, M. Marszalek, M. Roupret, C. G. Stief, Alessandro VOLPE, A. Minervini, O. Rodriguez-Faba

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

We performed a systematic review of long-term studies on drugs, metabolic diseases and dietary factors, and risk of prostate cancer considering the impact of prostate-specific antigen testing and found low-quality evidence of modest effects for some of them.
Lingua originaleInglese
pagine (da-a)1029-1057
Numero di pagine29
RivistaEuropean Urology Focus
Volume5
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Alpha reductase inhibitor
  • Aspirin
  • Body mass index
  • Diabetes
  • Diet
  • Food
  • Metabolic syndrome
  • Metformin
  • Nonsteroidal anti-inflammatory drugs
  • Obesity
  • Prostate cancer
  • Prostate-specific antigen test
  • Statin

Fingerprint

Entra nei temi di ricerca di 'Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology'. Insieme formano una fingerprint unica.

Cita questo